Comment on "Adverse Impacts of PEGylated Protein Therapeutics: A Targeted Literature Review".
作者信息
Goncalves Joao, Caliceti Paolo
机构信息
Faculty of Pharmacy, iMed-Research Institute for Medicines, University of Lisbon, Lisbon, Portugal.
Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy.
出版信息
BioDrugs. 2025 Jul;39(4):669-671. doi: 10.1007/s40259-025-00724-2. Epub 2025 Jun 17.
Abstract
摘要
相似文献
1
Comment on "Adverse Impacts of PEGylated Protein Therapeutics: A Targeted Literature Review".关于《聚乙二醇化蛋白质疗法的不良影响：针对性文献综述》的评论
BioDrugs. 2025 Jul;39(4):669-671. doi: 10.1007/s40259-025-00724-2. Epub 2025 Jun 17.
2
Author's Reply to Gonçalves: "Adverse Impacts of PEGylated Protein Therapeutics: A Targeted Literature Review".作者对贡萨尔维斯的回复：“聚乙二醇化蛋白质疗法的不良影响：一项针对性文献综述”
BioDrugs. 2025 Jul;39(4):673-674. doi: 10.1007/s40259-025-00725-1. Epub 2025 Jun 17.
3
Adverse Impacts of PEGylated Protein Therapeutics: A Targeted Literature Review.聚乙二醇化蛋白治疗药物的不良影响：有针对性的文献综述。
BioDrugs. 2024 Nov;38(6):795-819. doi: 10.1007/s40259-024-00684-z. Epub 2024 Oct 17.
4
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎：系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.
5
Pegylated interferon alpha-2a and -2b in combination with ribavirin in the treatment of chronic hepatitis C: a systematic review and economic evaluation.聚乙二醇化干扰素α-2a和α-2b联合利巴韦林治疗慢性丙型肝炎：系统评价与经济学评估
Health Technol Assess. 2004 Oct;8(39):iii-iv, 1-125. doi: 10.3310/hta8390.
6
Impacts of structuring the electronic health record: Results of a systematic literature review from the perspective of secondary use of patient data.构建电子健康记录的影响：从患者数据二次使用角度进行的系统文献综述结果
Int J Med Inform. 2017 Jan;97:293-303. doi: 10.1016/j.ijmedinf.2016.10.004. Epub 2016 Oct 4.
7
Review and synthesis of the global literature on domestic cat impacts on wildlife.综述全球有关家猫对野生动物影响的文献。
J Anim Ecol. 2022 Jul;91(7):1361-1372. doi: 10.1111/1365-2656.13745. Epub 2022 May 27.
8
Assessment of the Effects of Economic Sanctions on Iranians' Right to Health by Using Human Rights Impact Assessment Tool: A Systematic Review.使用人权影响评估工具评估经济制裁对伊朗人健康权的影响：系统评价。
Int J Health Policy Manag. 2018 May 1;7(5):374-393. doi: 10.15171/ijhpm.2017.147.
9
VIR-2218 (elebsiran) plus pegylated interferon-alfa-2a in participants with chronic hepatitis B virus infection: a phase 2 study.VIR-2218（elebsiran）联合聚乙二醇干扰素-α-2a 治疗慢性乙型肝炎病毒感染患者的 2 期研究。
Lancet Gastroenterol Hepatol. 2024 Dec;9(12):1121-1132. doi: 10.1016/S2468-1253(24)00237-1. Epub 2024 Oct 8.
10
Laser therapy for treating hypertrophic and keloid scars.激光疗法治疗增生性瘢痕和瘢痕疙瘩。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD011642. doi: 10.1002/14651858.CD011642.pub2.
引用本文的文献
1
Author's Reply to Gonçalves: "Adverse Impacts of PEGylated Protein Therapeutics: A Targeted Literature Review".作者对贡萨尔维斯的回复：“聚乙二醇化蛋白质疗法的不良影响：一项针对性文献综述”
BioDrugs. 2025 Jul;39(4):673-674. doi: 10.1007/s40259-025-00725-1. Epub 2025 Jun 17.
本文引用的文献
1
Relevance of Neutralizing Antibodies for the Pharmacokinetics of Pegunigalsidase Alfa in Patients with Fabry Disease.中和抗体对法布里病患者聚乙二醇化α-半乳糖苷酶药代动力学的影响
BioDrugs. 2025 Jan;39(1):153-165. doi: 10.1007/s40259-024-00690-1. Epub 2024 Nov 30.
2
Optimizing Pharmacological and Immunological Properties of Therapeutic Proteins Through PEGylation: Investigating Key Parameters and Their Impact.通过聚乙二醇化优化治疗性蛋白质的药理学和免疫学性质：研究关键参数及其影响。
Drug Des Devel Ther. 2024 Nov 7;18:5041-5062. doi: 10.2147/DDDT.S481420. eCollection 2024.
3
Adverse Impacts of PEGylated Protein Therapeutics: A Targeted Literature Review.聚乙二醇化蛋白治疗药物的不良影响：有针对性的文献综述。
BioDrugs. 2024 Nov;38(6):795-819. doi: 10.1007/s40259-024-00684-z. Epub 2024 Oct 17.
4
PEGylated therapeutics in the clinic.临床中的聚乙二醇化治疗药物。
Bioeng Transl Med. 2023 Sep 22;9(1):e10600. doi: 10.1002/btm2.10600. eCollection 2024 Jan.
5
Characterization of pre-existing anti-PEG and anti-AGAL antibodies towards PRX-102 in patients with Fabry disease.鉴定法布雷病患者体内针对 PRX-102 的抗聚乙二醇（PEG）和抗 A 型糖鞘脂酶（AGAL）抗体。
Front Immunol. 2023 Sep 22;14:1266082. doi: 10.3389/fimmu.2023.1266082. eCollection 2023.
6
Role of anti-polyethylene glycol (PEG) antibodies in the allergic reactions to PEG-containing Covid-19 vaccines: Evidence for immunogenicity of PEG.抗聚乙二醇（PEG）抗体在含 PEG 的 COVID-19 疫苗过敏反应中的作用：PEG 具有免疫原性的证据。
Vaccine. 2023 Jul 12;41(31):4561-4570. doi: 10.1016/j.vaccine.2023.06.009. Epub 2023 Jun 5.
7
Anti-PEG Antibodies Boosted in Humans by SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine.SARS-CoV-2脂质纳米颗粒mRNA疫苗可增强人体中的抗聚乙二醇抗体。
ACS Nano. 2022 Aug 23;16(8):11769-11780. doi: 10.1021/acsnano.2c04543. Epub 2022 Jun 27.
8
Pre-existing anti-polyethylene glycol antibody reduces the therapeutic efficacy and pharmacokinetics of PEGylated liposomes.预先存在的抗聚乙二醇抗体降低了聚乙二醇化脂质体的治疗效果和药代动力学。
Theranostics. 2018 May 9;8(11):3164-3175. doi: 10.7150/thno.22164. eCollection 2018.
9
Efficacy and safety of native versus pegylated Escherichia coli asparaginase for treatment of adults with high-risk, Philadelphia chromosome-negative acute lymphoblastic leukemia.天然型与聚乙二醇化大肠杆菌天冬酰胺酶治疗高危、费城染色体阴性成人急性淋巴细胞白血病的疗效与安全性
Leuk Lymphoma. 2018 Jul;59(7):1634-1643. doi: 10.1080/10428194.2017.1397661. Epub 2017 Nov 22.
10
Randomized, double-blind clinical trial comparing basal insulin peglispro and insulin glargine, in combination with prandial insulin lispro, in patients with type 1 diabetes: IMAGINE 3.1型糖尿病患者中，比较聚乙二醇化赖脯胰岛素与甘精胰岛素联合餐时赖脯胰岛素的随机双盲临床试验：IMAGINE 3
Diabetes Obes Metab. 2016 Nov;18(11):1081-1088. doi: 10.1111/dom.12698. Epub 2016 Aug 3.
Zotero 插件